Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

March 14, 2017

Indian Researchers Report Rare Case of Mesothelioma in Chest, Abdominal Cavities

News

Doctors in India report the unusual case of a 40-year-old woman afflicted with pleuroperitoneal mesothelioma, a rare form of mesothelioma that affects both the pleura and the peritoneum. Their study, ... Read more

March 9, 2017

Researchers Develop More Feasible Method for Distinguishing MPM from Benign RMH

News

Immunohistochemistry, an imaging technique to detect the loss of two proteins, MTAP and BAP1, may help doctors distinguish between malignant pleural mesothelioma (MPM) and reactive mesothelial hyperplasia (RMH), according to a ... Read more

March 7, 2017

Surgery Eliminates Two Men’s Testicular Mesothelioma, Case Study Reports

News

Surgery eliminated benign testicular mesothelioma in two men with the rare cancer, according to a case study. The research, “Two Case Reports Of Benign Testicular Mesothelioma And Review Of The ... Read more

March 3, 2017

Antiviral, Cidofovir, Seen to Kill Mesothelioma and Other Cancer Cells in Early Study

News

Treatment with cidofovir, a well-recognized antiviral drug, has shown promise in killing several types of cancer cells, including mesothelioma, data in a preclinical study show. The study, “Reduced Cell Viability ... Read more

March 1, 2017

High Temperature Platinol Shows Promise in Treating Malignant Pleural Effusion

News

Injecting heated chemotherapy into the pleural cavity, the region between the two thin layers lining the lungs, is a promising approach for patients who present with malignant pleural effusion (MPE) — ... Read more

February 21, 2017

Long-term Chemo Improves Abdominal Mesothelioma Patients’ Survival Rates, Study Suggests

News

Long-term localized chemotherapy may significantly improve survival in patients with malignant peritoneal mesothelioma (MPM), according to a study. The research, “Long-Term Regional Chemotherapy For Patients With Epithelial Malignant Peritoneal Mesothelioma ... Read more

February 9, 2017

Image-Guided Needle Biopsies Could Replace Invasive Diagnostic Procedures for Pleural Mesothelioma, Study Suggests

News

Percutaneous image-guided biopsies are very sensitive in detecting malignant pleural mesothelioma (MPM) with few complications, and may decrease the need for surgical biopsies, according to a new study. The study, “A Single-Institution ... Read more

February 7, 2017February 7, 2017

MUC4 Protein, or Its Lack, Seen to Aid in Diagnosing Pleural Mesothelioma Subtype

News

The lack of a specific protein, MUC4, may be a valuable biomarker in distinguishing sarcomatoid mesothelioma from lung sarcomatoid carcinoma, a disease for which it is often mistaken, according to ... Read more

February 3, 2017

microRNA Seen to Control Mesothelin Levels, Cancer Growth in Mesothelioma Cell Study

News

Mesothelin, a gene that is highly expressed in mesothelioma and other cancers, is thought to have a driving role in this disease, regulating cancer cell proliferation and ability to invade ... Read more

January 26, 2017

Levels of Fibulin-3 Protein Could Help Diagnose Malignant Mesothelioma, Study Suggests

News

High levels of the protein fibulin-3 in the blood or the pleural effusion — the fluid that often accumulates in the space between the lung and chest wall of patients ... Read more